115 related articles for article (PubMed ID: 29240787)
1. BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.
Carretta M; Brouwers-Vos AZ; Bosman M; Horton SJ; Martens JHA; Vellenga E; Schuringa JJ
PLoS One; 2017; 12(12):e0189102. PubMed ID: 29240787
[TBL] [Abstract][Full Text] [Related]
2. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
[TBL] [Abstract][Full Text] [Related]
3. Differential requirement for wild-type Flt3 in leukemia initiation among mouse models of human leukemia.
Kamezaki K; Luchsinger LL; Snoeck HW
Exp Hematol; 2014 Mar; 42(3):192-203.e1. PubMed ID: 24269847
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
Dawson MA; Prinjha RK; Dittmann A; Giotopoulos G; Bantscheff M; Chan WI; Robson SC; Chung CW; Hopf C; Savitski MM; Huthmacher C; Gudgin E; Lugo D; Beinke S; Chapman TD; Roberts EJ; Soden PE; Auger KR; Mirguet O; Doehner K; Delwel R; Burnett AK; Jeffrey P; Drewes G; Lee K; Huntly BJ; Kouzarides T
Nature; 2011 Oct; 478(7370):529-33. PubMed ID: 21964340
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model.
Danis E; Yamauchi T; Echanique K; Haladyna J; Kalkur R; Riedel S; Zhu N; Xie H; Bernt KM; Orkin SH; Armstrong SA; Neff T
Exp Hematol; 2015 Nov; 43(11):930-935.e6. PubMed ID: 26118502
[TBL] [Abstract][Full Text] [Related]
6. Signal peptide-CUB-EGF-like repeat-containing protein 1-promoted FLT3 signaling is critical for the initiation and maintenance of MLL-rearranged acute leukemia.
Sahoo BK; Lin YC; Tu CF; Lin CC; Liao WJ; Li FA; Li LH; Mou KY; Roffler SR; Wang SP; Yeh CT; Yao CY; Hou HA; Chou WC; Tien HF; Yang RB
Haematologica; 2023 May; 108(5):1284-1299. PubMed ID: 36005562
[TBL] [Abstract][Full Text] [Related]
7. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of HOXA4, HOXA7, HOXA10, HOXA11 and MEIS1 during monocyte-macrophage differentiation in THP-1 cells.
Martino V; Bianchera A; Reia L; Bussolati O; Fazzina R; Marino F; Montemurro L; Tonelli R; Pession A; Gazzola GC; Sala R
Mol Med Rep; 2009; 2(2):241-4. PubMed ID: 21475819
[TBL] [Abstract][Full Text] [Related]
9. Histone H3K36me2-Specific Methyltransferase ASH1L Promotes MLL-AF9-Induced Leukemogenesis.
Aljazi MB; Gao Y; Wu Y; Mias GI; He J
Front Oncol; 2021; 11():754093. PubMed ID: 34692539
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the Importance of DOT1L Recruitment in MLL-AF9 Leukemia and Hematopoiesis.
Grigsby SM; Friedman A; Chase J; Waas B; Ropa J; Serio J; Shen C; Muntean AG; Maillard I; Nikolovska-Coleska Z
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562706
[No Abstract] [Full Text] [Related]
11. [Establishment of the retrovirus-mediated murine model with MLL-AF9 leukemia].
Xu SM; Yang Y; Zhou M; Zhao XJ; Qin Y; Zhang PL; Yuan RF; Zhou JF; Fang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1126-32. PubMed ID: 24156419
[TBL] [Abstract][Full Text] [Related]
12. [Effect of MLL-AF9 fusion gene silence of acute monocytic leukemia cell line THP-1 on cyclin-dependent kinase inhibitor p27 expression].
Li L; Liu LB; Wang L; Zou P
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):375-8. PubMed ID: 19031738
[TBL] [Abstract][Full Text] [Related]
13. The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells.
Srinivasan RS; Nesbit JB; Marrero L; Erfurth F; LaRussa VF; Hemenway CS
Leukemia; 2004 Aug; 18(8):1364-72. PubMed ID: 15269783
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid inhibits the growth of leukemic MLL-AF9 transformed hematopoietic cells.
Chiarella E; Codispoti B; Aloisio A; Cosentino EG; Scicchitano S; Montalcini Y; Lico D; Morrone G; Mesuraca M; Bond HM
Heliyon; 2020 Jun; 6(6):e04020. PubMed ID: 32529062
[TBL] [Abstract][Full Text] [Related]
15. Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway.
Yao Q; Nishiuchi R; Kitamura T; Kersey JH
Leukemia; 2005 Sep; 19(9):1605-12. PubMed ID: 16034464
[TBL] [Abstract][Full Text] [Related]
16. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
[TBL] [Abstract][Full Text] [Related]
17. Synergism between etoposide and 17-AAG in leukemia cells: critical roles for Hsp90, FLT3, topoisomerase II, Chk1, and Rad51.
Yao Q; Weigel B; Kersey J
Clin Cancer Res; 2007 Mar; 13(5):1591-600. PubMed ID: 17332306
[TBL] [Abstract][Full Text] [Related]
18. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
[TBL] [Abstract][Full Text] [Related]
19. [Effect of down-regulating mll-af9 gene expression on proliferation of acute monocytic leukemia cell line THP-1].
Li L; Zhang AH; Liu LB; Bi L; Wang L; Zhao YJ; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):254-7. PubMed ID: 18426643
[TBL] [Abstract][Full Text] [Related]
20. Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity.
Ui A; Yasui A
Nucleus; 2016 Apr; 7(2):138-45. PubMed ID: 27310306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
